Despite of its beneficial effects towards different diseases such as cardiovascular disease, cancer and neuerodegenerative diseases, the low bioavailability of reseveratrol can be mainly attributed to the efficient elimination by intestinal BCRP and phase II metabolism [16]. The gene discussed is ABCG2; the disease is cancer.